Bell-Meyer brings with her over 10 years’ experience working with chambers of commerce and economic development initiatives.
Westchester Advanced Manufacturing Firm Expands Operations with New Lease Deal
ELMSFORD—Robert Martin Company announced recently that PTI, a leader in advanced manufacturing technologies, has signed a lease for 13,650 square feet of expansion space at 8 Skyline Drive at the Mid-Westchester Executive Park in Hawthorne.
PTI, which manufactures non-destructive package inspection technologies for the pharmaceutical, medical device and food industries, previously signed a lease for 14,255 square feet at 8 Skyline Drive in 2018. The space incorporated PTI’s executive offices, sales department, research and development, manufacturing and shipping and receiving functions. With this new lease, PTI now occupies approximately 28,000 square feet at 8 Skyline Drive, nearly four times the size of its original offices in Tuckahoe.
“PTI’s considerable expansion at our Mid-Westchester Executive Park represents the kind of entrepreneurial, innovative technology companies we are targeting for growth through the RMC Bio1 initiative we launched in late 2019,” said Tim Jones, CEO of Robert Martin Company.
RMC Bio1 focuses primarily on attracting life sciences and health technologies companies transitioning from start-up incubators and accelerator programs into larger “graduation” spaces, as well as working on the retention of existing small-to-midsize firms in Westchester in need of expanding their operations. This includes providing flexible spaces for light manufacturing, labs and/or offices designed especially for high-growth potential companies utilizing the latest in R&D workflow techniques.
Robert Martin Company President Greg Berger said, “Skyline Drive’s repositioning as an innovation corridor for the life sciences and health technologies industry is bearing fruit. PTI’s expansion is evidence of a longer-term trend that will benefit the Westchester economy for years to come.”
RMC Bio1 Managing Director, Laurence Gottlieb, noted that the expansion of larger scientific research and development companies such as Regeneron Pharmaceuticals naturally creates start-up and expansion opportunities for companies in related fields that feed off that growth. “We envisioned Skyline Drive evolving into ‘Bio Boulevard,’ as more STEM-related companies join the fold and eventually connect into the larger ‘Innovation Corridor’ forming around an epicenter in Westchester County, which includes formidable assets such as Regeneron, Acorda Therapeutics, New York Medical College, BioInc@NYMC, Westchester Medical Center and the planned North 60 life sciences campus.”
Howard Greenberg, of Howard Properties, Ltd. of Valhalla, represented PTI in both the original and expansion lease transactions.
The PTI lease is the second transaction in several months at Skyline Drive which is emerging as a center for companies in the bioscience and medical device field, In October, Clarapath leased 7,000 square feet at 12 Skyline Drive. The company, which is moving from New York City, is a developer of an integrated histology platform designed to standardize and digitally transform anatomic pathology. The company plans to use the new space for the light manufacturing of its medical tech equipment.